Adenocaine was developed to provide a natural, reproducible form of myocardial protection during invasive procedures.
Adenocaine has been extensively studied, and has been in clinical use for well over a decade. The patented formulation of adenosine, lidocaine, and magnesium is produced and distributed under 503b regulations and quality controls.
Adenocaine mimics the biological processes that occur during mammalian hibernation, resulting in a unique, polarized cardiac arrest and natural, spontaneous restart.
Adenocaine has been shown effective in maintaining arrest through long, complex procedures with extended cross-clamp times.
Sign up to hear from us about publications, demonstrations, and events.